Cefuroxime
Ceroxim is an antibiotic that is used in adults and children. It works by killing the bacteria that cause infections. It belongs to a group of medicines called cephalosporins.
Ceroxim is used to treat infections of:
This medicine may also be used to treat early stages of Lyme disease (borreliosis - an infection spread by ticks).
Your doctor may test the type of bacteria that is causing your infection and make sure that they are susceptible to Ceroxim during treatment.
If any of the above applies to you, do not take Ceroxim without consulting your doctor.
Before taking Ceroxim, you should tell your doctor if:
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported with cefuroxime. If you get any of the symptoms listed in section 4, you should contact your doctor immediately.
Ceroxim is not recommended for use in children under 3 months of age, as its safety and effectiveness have not been established in this age group.
While taking Ceroxim, you should be aware of the following:
allergic reactions, fungal infections (e.g. thrush) or severe diarrhea (pseudomembranous colitis). This will reduce the risk of complications. See "Special warnings and precautions for use" in section 4.
Ceroxim may affect the results of a blood test for sugar in your blood (glucose) and a test called the Coombs test.
If you are going to have a blood test, tell the person taking your blood that you are taking Ceroxim.
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, and those you plan to take.
If you are taking any of these medicines, tell your doctor.
If you are pregnant, think you might be pregnant, are planning to become pregnant or are breast-feeding, ask your doctor or pharmacist for advice before taking this medicine.
Ceroxim may cause dizziness or other side effects that may affect your ability to concentrate.
Do not drive or operate machinery if you do not feel well.
Ceroxim contains less than 1 mmol (23 mg) of sodium per tablet, which is essentially "sodium-free".
Always take Ceroxim exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Ceroxim should be taken after food. This will increase the effectiveness of your treatment.
Swallow the tablets whole with water. Do not chew, crush or break them.
The recommended dose of Ceroxim is 250 mg to 500 mg twice daily, depending on the severity and type of infection.
The recommended dose of Ceroxim is 10 mg/kg body weight (not more than 125 mg) to 15 mg/kg body weight (not more than 250 mg) twice daily, depending on the severity and type of infection.
Ceroxim is not recommended for use in children under 3 months of age, as its safety and effectiveness have not been established in this age group.
Depending on the disease and how your child responds to treatment, the initial dose may be changed or more than one course of treatment may be needed.
If you have kidney disease, tell your doctor. Your doctor may need to adjust your dose.
If you take more Ceroxim than you should, you may experience neurological disorders, particularly an increased risk of seizures (convulsions).
Contact your doctor or the nearest hospital emergency department immediately. If possible, show them the Ceroxim packaging.
Do not take a double dose to make up for a forgotten dose. Take the next dose at the usual time.
Do not stop taking Ceroxim without consulting your doctor.
It is important that you complete the course of treatment, even if you start to feel better. Stopping treatment too soon may result in the infection returning.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Ceroxim can cause side effects, although not everybody gets them.
A small number of people taking Ceroxim have reported an allergic reaction or potentially serious skin reaction. The symptoms may be:
If you experience any of these symptoms, contact your doctor or nurse immediately.
Common Side Effects(may affect up to 1 in 10 people):
Common side effects seen in blood tests:
Uncommon Side Effects(may affect up to 1 in 100 people):
Uncommon side effects seen in blood tests:
Other side effects have been reported in a small number of people, but the frequency of these side effects is not known:
Side effects seen in blood tests:
If you experience any side effects, talk to your doctor or pharmacist or nurse. You can also report side effects directly via the national reporting system listed in the "Further information" section.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.
United Kingdom: Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard
Ireland: HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2, Tel: +353 1 6764971, Fax: +353 1 6762517, Website: www.hpra.ie, E-mail: [medsafety@hpra.ie](mailto:medsafety@hpra.ie)
Malta: ADR Reporting, Website: www.medicinesauthority.gov.mt/adrportal
Keep this medicine out of the sight and reach of children.
Do not use Ceroxim after the expiry date which is stated on the blister and carton. The expiry date refers to the last day of that month.
There are no special storage conditions.
Do not use Ceroxim if you notice that the tablets are broken or damaged.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
The active substance is cefuroxime (as cefuroxime axetil). Each film-coated tablet contains 250 mg or 500 mg of cefuroxime.
The other ingredients are:
Tablet core: microcrystalline cellulose (PH101), microcrystalline cellulose (PH112), croscarmellose sodium, sodium lauryl sulfate, hydrogenated vegetable oil, colloidal anhydrous silica
Coating: Opadry White OY-S-58910: hypromellose (5 cp), titanium dioxide (E 171), macrogol 400, talc
250 mg film-coated tabletsare white to off-white, capsule-shaped, with "250" engraved on one side and smooth on the other. The tablets are 15.0 mm long, 6.5 mm wide and 5.05 mm thick. They are packaged in PVC/Aclar/Aluminum blisters in a carton. The carton contains 10, 12, 14, 20 or 24 film-coated tablets.
500 mg film-coated tabletsare white to off-white, capsule-shaped, with "500" engraved on one side and smooth on the other. The tablets are 18.0 mm long, 9.0 mm wide and 6.95 mm thick. They are packaged in PVC/Aclar/Aluminum blisters in a carton. The carton contains 10, 12, 14, 20 or 24 film-coated tablets.
Not all pack sizes may be marketed.
Ranbaxy (Poland) Sp. z o. o.
ul. Idzikowskiego 16
00-710 Warsaw
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132 JH Hoofddorp
Netherlands
Alkaloida Chemical Company Zrt.
4400 Tiszavasvári
Kabay János u. 29
Hungary
Terapia SA
Str. Fabricii nr 124
400 632 Cluj Napoca
Romania
Netherlands: Cefuroxim SUN 250 mg filmomhulde tabletten
Cefuroxim SUN 500 mg filmomhulde tabletten
Czech Republic: Znobact 500 mg potahované tablety
Hungary: Ceroxim 500 mg filmtabletta
Germany: CEFUROX BASICS 250mg (500mg) Filmtabletten
Slovakia: Znobact 500 mg filmom obalené tablety
Spain: Cefuroxima SUN 500 mg comprimidos recubiertos con película EFG
Date of Last Revision of the Leaflet:26.05.2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.